Correction to: Drugs R D (2018) 18:119–128 10.1007/s40268-018-0231-2
In the Original Publication, Table 1 has error in the values. The values in the second column (LAC) and third column (Metastatic cancer) need to be swapped around.
Table 1 which currently reads:
Table 1.
Patient demographics for the analyzed subgroups
| Characteristic | LAC | Metastatic cancer | Fentanyl | Oxycodone/naloxone |
|---|---|---|---|---|
| Age (years) | 22 (70.4 ± 13.2) | 54 (70.2 ± 11.9) | 27 (67.7 ± 12.3) | 24 (72.5 ± 10.5) |
| Sex | ||||
| Male | 8 (34.8) | 21 (36.2) | 15 (51.7) | 15 (62.5) |
| Female | 15 (65.2) | 37 (63.8) | 14 (48.3) | 9 (37.5) |
| Weight (kg) | 20 (65.1 ± 13.7) | 53 (72.1 ± 13.9) | 26 (68.0 ± 12.4) | 21 (73.7 ± 14.7) |
Data are presented as n (%) or N (mean ± standard deviation)
LAC locally advanced cancer
Should read:
Table 1.
Patient demographics for the analyzed subgroups
| Characteristic | LAC | Metastatic cancer | Fentanyl | Oxycodone/naloxone |
|---|---|---|---|---|
| Age (years) | 54 (70.2 ± 11.9) | 22 (70.4 ± 13.2) | 27 (67.7 ± 12.3) | 24 (72.5 ± 10.5) |
| Sex | ||||
| Male | 21 (36.2) | 8 (34.8) | 15 (51.7) | 15 (62.5) |
| Female | 37 (63.8) | 15 (65.2) | 14 (48.3) | 9 (37.5) |
| Weight (kg) | 53 (72.1 ± 13.9) | 20 (65.1 ± 13.7) | 26 (68.0 ± 12.4) | 21 (73.7 ± 14.7) |
Data are presented as n (%) or N (mean ± standard deviation)
LAC locally advanced cancer